Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 12139470
Trioxolane agents
granted -
US 12139486
Octahydro fused azadecalin glucocorticoid receptor modulators
granted -
US 12138276
Halogenated psilocybin derivatives and methods of using
granted -
US 12138247
Non-sedating dexmedetomidine treatment regimens
granted -
US 12138294
Transgenic corn with antifungal peptide AGM182 (DN:0113.18)
granted -
US 12138263
Pyrazolo[3,4-b]pyrazine SHP2 phosphatase inhibitors and methods of use thereof
granted -
US 12138272
Methods and compositions for treating amyotrophic lateral sclerosis
granted -
US 12139499
Heteroaryl compounds for treating Huntington's disease
granted -
US 12138233
Methods of treating idiopathic hypersomnia
granted -
US 12138301
Compounds including a mutant KRAS sequence and a lipid and uses thereof
granted -
US 12139711
Antisense oligonucleotides for the treatment of Leber congenital amaurosis
granted -
US 12139522
T-cells comprising two different chimeric antigen receptors and uses thereof
granted -
US 12138243
Antiviral use of FABP4 modulating compounds
granted -
US 12138312
Cell-penetrating peptides for antisense delivery
granted -
US 12138274
Compositions and methods for the treatment of peripheral artery disease and cardiopulmonary diseases
granted -
US 12139764
Systems and methods for characterizing and treating breast cancer
granted -
US 12139709
Antisense oligomers and methods of using the same for treating diseases associated with the acid alpha-glucosidase gene
granted -
US 2024368250
POLYPEPTIDES BINDING TO THE NEONATAL FC RECEPTOR
granted -
US 12134767
Materials and methods for treatment of hemoglobinopathies
granted -
US 12134651
Anti-Ryk antibodies and methods of using the same
granted -
US 12134650
Compositions targeting GABRA2 and methods for diagnosis and treatment of cancer
granted -
US 12134648
Dual specificity antibodies to human PD-L1 and PD-L2 and methods of use therefor
granted -
US 12134642
Antibodies binding to α7β1 integrin antibodies and compositions thereof
granted -
US 12134631
Hydrophilic linkers for antibody drug conjugates
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.